[Osteoporosis. Detection, prevention, and treatment]

Area of Science:

• Bone biology and metabolic disorders
• Geriatric medicine and endocrinology
• Pharmacology and therapeutic interventions

Context:

• Osteoporosis is characterized by decreased bone mineral density (osteopenia) and impaired bone quality, leading to fractures.
• Metabolic disturbances, often multifactorial and not fully understood, underlie this condition.
• Early detection of osteopenia is crucial for fracture risk assessment.

Purpose:

• To review the characteristics, diagnosis, and therapeutic strategies for osteoporosis.
• To highlight the importance of nutritional and lifestyle factors in bone health.
• To discuss current and emerging pharmaceutical treatments for osteoporosis.

Summary:

• Osteoporosis involves bone loss and microarchitectural damage, diagnosed by fractures or deformations.
• Biochemical markers like alkaline phosphatase and hydroxyproline aid in assessment.
• Nutritional support (calcium, Vitamin D) and physical activity are vital, especially during growth.
• Therapeutic options include hormone replacement therapy, calcitonin, bisphosphonates, and other agents under investigation.
• Bisphosphonates, like pamidronate, show promise by not interfering with bone remodeling.

Impact:

• Provides a comprehensive overview of osteoporosis management strategies.
• Emphasizes the role of early intervention and preventative measures.
• Informs about the efficacy and limitations of various pharmacological treatments for osteoporosis.